Cargando…

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy

Carbohydrate antigen 19-9 (CA19-9) is one of the most widely used tumor markers in gastrointestinal cancer. However, serum CA19-9 is not a recommended routine measurement in colon cancer. In this study, we evaluated the value of the preoperative serum CA19-9 level for the prediction of postoperative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wenhao, Yang, Fan, Peng, Jianhong, Wang, Fulong, Lin, Yuzhu, Jiang, Wu, Yang, Xia, Li, Liren, Lu, Zhenhai, Wan, Desen, Pan, Zhizhong, Fan, Wenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636281/ https://www.ncbi.nlm.nih.gov/pubmed/31333798 http://dx.doi.org/10.7150/jca.31375

Ejemplares similares

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
por: Peng, Jianhong, et al.
Publicado: (2018)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial
por: Wang, Fulong, et al.
Publicado: (2018)

Efficacy and safety of a NiTi CAR 27 compression ring for end-to-end anastomosis compared with conventional staplers: A real-world analysis in Chinese colorectal cancer patients
por: Lu, Zhenhai, et al.
Publicado: (2016)

Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
por: Peng, Jianhong, et al.
Publicado: (2020)

Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer
por: Peng, Jianhong, et al.
Publicado: (2017)

TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection
por: Peng, Jianhong, et al.
Publicado: (2019)

Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study
por: Peng, Jianhong, et al.
Publicado: (2017)

Hepatitis B Virus Infection Predicts Better Survival In Patients With Colorectal Liver-only Metastases Undergoing Liver Resection
por: Zhao, Yujie, et al.
Publicado: (2018)

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection
por: Deng, Yuxiang, et al.
Publicado: (2018)

Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis
por: Peng, Jianhong, et al.
Publicado: (2017)

Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer
por: Peng, Jianhong, et al.
Publicado: (2021)

Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis
por: Lin, Junzhong, et al.
Publicado: (2017)

Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer
por: Song, Ji Hyeong, et al.
Publicado: (2022)

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients
por: Zhang, Linjie, et al.
Publicado: (2023)

Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience
por: Peng, Jianhong, et al.
Publicado: (2019)

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer
por: Peng, Jianhong, et al.
Publicado: (2016)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
por: Lee, Choong-kun, et al.
Publicado: (2019)

PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma
por: Kim, Hyo Song, et al.
Publicado: (2016)

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)

Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?
por: Manzini, Giulia, et al.
Publicado: (2020)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
por: Lin, Dagui, et al.
Publicado: (2021)

Does the Preoperative Prognostic Nutritional Index Predict Survival in Patients with Liver Metastases from Colorectal Cancer Who Underwent Curative Resection?
por: Zhao, Yujie, et al.
Publicado: (2018)

Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
por: Kim, Joo Hoon, et al.
Publicado: (2016)

Nerve invasion as an independent predictor of poor prognosis in gastric cancer after curative resection
por: Li, Chunsheng, et al.
Publicado: (2022)

High WNT6 expression indicates unfavorable survival outcome for patients with colorectal liver metastasis after liver resection
por: Peng, Jianhong, et al.
Publicado: (2019)

Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)

Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes
por: Peng, Jianhong, et al.
Publicado: (2017)

Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival
por: Peng, Jianhong, et al.
Publicado: (2017)

Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy
por: Peng, Jianhong, et al.
Publicado: (2021)

Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection
por: Deng, Yuxiang, et al.
Publicado: (2019)

The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.
por: Hall, N. R., et al.
Publicado: (1994)

Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection
por: Leng, Kai-Ming, et al.
Publicado: (2017)

Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection
por: Ye, Yanyan, et al.
Publicado: (2023)

Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2020)

The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis
por: Ng, Kheng-Seong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n0ils1tc7ne8a8kq202g6pjsnv